MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0039503
HWLC Pharmaceuticals Private Limited - chemicals in Hyderabad, Telangana, India. Directors, charges & compliance details.
Revenue · FY 2024
₹66.18 Lakh
▲ 31% YoY
Net loss · FY 2024
₹51,600
Net margin -0.8%
EBITDA · FY 2024
-₹10,100
EBITDA margin -0.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹7.14 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
4
As per MCA filings
Last financials
Mar 2024
Balance sheet date
About HWLC Pharmaceuticals Private Limited
Data last updated:
HWLC Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 26 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2020PTC145243.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7.14 Lakh. It is led by directors including Ibrahim Mohammed (Managing Director) and Rasheed Pasha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No.16 – 11 – 741/C/A/10 Moosarambagh Dilsukhnagar Malakpet, Hyderabad, Telangana, India – 500036.
As per the financials filed for FY 2024, the company reported a revenue of ₹66.18 Lakh, a growth of 31% compared to the previous year. For the same year it recorded a net loss of ₹51,600 (net margin -0.8%) and EBITDA of -₹10,100 (EBITDA margin -0.2%). Revenue has grown at a compounded annual rate (CAGR) of 118% over three years.
HWLC Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0039503). For more details, the company can be reached via its website hwlcpharma.com.
Company details
CIN U24230TG2020PTC145243
Registration Number 145243
Incorporation Date 26 October 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0039503
Recognitions & Rankings of HWLC Pharmaceuticals
Contact details
HWLC Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressNo.16 – 11 – 741/C/A/10 Moosarambagh Dilsukhnagar Malakpet, Hyderabad, Telangana, India – 500036
- IndustryChemicals, Manufacturing, Other Chemical Product
Comprehensive company report
HWLC Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of HWLC Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of HWLC Pharmaceuticals Private Limited, buy the company report.
Financials of HWLC Pharmaceuticals Private Limited
FY 2024 filings availableHWLC Pharmaceuticals Private Limited reported revenue of ₹66.18 Lakh (up 31% YoY) for FY 2024.
Revenue · FY 2024
₹66.18 Lakh ▲ 31%
Net loss · FY 2024
₹51,600 margin -0.8%
EBITDA · FY 2024
-₹10,100 margin -0.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 31%
3 years · compounded
▲ 118%
EBITDA CAGR growth
1 year
▲ 98%
3 years · compounded
▲ 74%
Revenue has grown at a compounded annual rate (CAGR) of 118% over three years, including 31% growth in the latest year. EBITDA rose 98% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹10,100 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹51,600 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -0.2% | |||
| Net Profit Margin | -0.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of HWLC Pharmaceuticals Private Limited, buy the company report.
Board of directors of HWLC Pharmaceuticals Private Limited
HWLC Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ibrahim Mohammed | Managing Director | 26 Oct 2020 | 6 Years 0 Months | Current |
| Rasheed Pasha | Director | 26 Oct 2020 | 6 Years 0 Months | Current |
| Mohammed Aijaz | Director | 26 Oct 2020 | 6 Years 0 Months | Current |
| Mohammed Amman Khan | Director | 10 Oct 2023 | 3 Years 0 Months | Current |
Peer comparison
HWLC Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Modgal Pharmaceuticals Pvt Ltd | ₹66.64 Lakh (FY 2025) | 12.0% | Delhi, India | |||
| Emmy Pharmaceuticals Private Limited | ₹66.38 Lakh (FY 2025) | -4.0% | Bhopal, Madhya Pradesh, India | |||
| HWLC Pharmaceuticals Private Limitedthis company | ₹66.18 Lakh (FY 2024) | -₹51,600 | -0.8% | 31.0% | Hyderabad, Telangana, India | |
| G and B Pharmaceuticals Private Limited | ₹65.84 Lakh (FY 2023) | 294.0% | Jagadhri, Haryana, India | |||
| Noventia Pharmaceuticals Private Limited | ₹65.33 Lakh (FY 2024) | 15.0% | Pune, Maharashtra, India |
To see the full peer comparison of HWLC Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving HWLC Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for HWLC Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for HWLC Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
HWLC Pharmaceuticals Private Limited has 6 board changes on record since 2020: 5 appointments and 1 cessation. The latest: Mohammed Amman Khan was appointed as Director on 10 Oct 2023.
AGM
Hwlc Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Hwlc Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Appointed
Mohammed Amman Khan was appointed as Director.
Ceased
Akram Shareef Shake ceased to be Additional Director.
Appointed
Akram Shareef Shake was appointed as Additional Director.
Appointed
Ibrahim Mohammed was appointed as Managing Director.
Appointed
Mohammed Aijaz was appointed as Director.
Appointed
Rasheed Pasha was appointed as Director.
Incorporation
26 Oct 2020
Hwlc Pharmaceuticals Private Limited was registered on 26 Oct 2020 with Roc Hyderabad & aged 6 years 13 days as per MCA records.
Frequently asked questions
HWLC Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 26 October 2020 (6+ years old) and is registered under CIN U24230TG2020PTC145243.
HWLC Pharmaceuticals has 4 current directors:
- Ibrahim Mohammed - Managing Director
- Rasheed Pasha - Director
- Mohammed Aijaz - Director
- Mohammed Amman Khan - Director
The latest financial statements of HWLC Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of HWLC Pharmaceuticals is U24230TG2020PTC145243. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
HWLC Pharmaceuticals was incorporated on 26 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of HWLC Pharmaceuticals by revenue are Modgal Pharmaceuticals Pvt Ltd, Emmy Pharmaceuticals Private Limited, G and B Pharmaceuticals Private Limited, Noventia Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mohammed Amman Khan was appointed as Director on 10 Oct 2023. Akram Shareef Shake ceased to be Additional Director on 16 Dec 2022. Akram Shareef Shake was appointed as Additional Director on 25 Nov 2020. HWLC Pharmaceuticals has 6 board changes on record in total.
Yes, HWLC Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0039503).
HWLC Pharmaceuticals can be reached through the website hwlcpharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of HWLC Pharmaceuticals is at No.16 – 11 – 741CA10 Moosarambagh Dilsukhnagar Malakpet, Hyderabad, Telangana, India – 500036.
HWLC Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages